Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: The fundamentals of the company has changed
  1. Production is guaranteed. Before, we were marred with delays and uncertainty. That is no more.
  2. The company most likely will get some cash injection from the warrants, critical for eliminating funding worries.
  3. With funding no longer a concern and volume ramp in sight, the stock most likely will re-rate. Assuming we reach ATH again, the cost to finance 12 months at current burn rate is only 10% dilution, if there ever is another raise.
  4. The transition to being a transceiver maker will turn the initial $300M SAM into $3B SAM. The stock price will reflect this, even if it doesn't account for:
  5. The other verticals that hasn't seen major announcements. We still have the wearable/health tech vertical. A collab with a major tech or healthcare firm is still in play.
  6. Exposure to US investor base has barely begun. You will know we got into mainstream when the day volume equals 50% of the float.
Share
New Message
Please login to post a reply